Jubilant Pharmova Ltd - Company Profile
Powered by 
All the data and insights you need on Jubilant Pharmova Ltd in one report.
$295
- Save hours of research time and resources with
our up-to-date Jubilant Pharmova Ltd Strategy Report
- Understand Jubilant Pharmova Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Related keylists
Business Description
Jubilant Pharmova Ltd (Jubilant) manufactures and supplies APIs, solid dosage formulations, allergy therapy products, radiopharmaceuticals, fine ingredients, advance intermediates, life science chemicals, crop science ingredients and nutritional products. Jubilant also offers contract manufacturing services for sterile injectables and drug discovery solutions. The company operates six manufacturing facilities, including four in North America and two in India, catering to all the regulated markets such as the US, Europe, Australia, and two in India for contract research.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
R&D Overview
Jubilant Pharmova's R&D activities are dedicated to fostering innovation, scientific efficiency, and adherence to core values in alignment with business strategies. Located in North America, the R&D centers specialize in developing novel, robust, and non-infringing processes for specialized formulations, particularly in the field of radiopharmaceuticals. The company is actively engaged in R&D related to allergy diagnostics and therapeutics, focusing on biopharmaceuticals and sterile liquid vaccines for immunotherapy, offering solutions for allergies caused by companion animals, mites, pollen, dust, and more. As of March 31, 2023, the company had filed for 357 API patent applications and had 132 granted patents. The company has filed 1,000 ANDAs in the US, 38 in Europe, 25 in Canada and 44 in rest of the world. As of March 31, 2023, the company had filed 98 Drug Master Files (DMF’s); 46 Certification of Suitability (CEPs) in Europe, 113 Active Substance Master Files (ASMFs) in Europe; 42 DMFs in Canada, 15 DMFs in Japan, 14 DMFs in Australia and 3 CADIFA DMF filings in Brazil. In FY2023, the company’s R&D expenditure stood at INR272.4 million, which grew 4.7% YoY and accounted for 0.4% of the company’s total revenue.
Business Segments
- Generics
- Allergy Immunotherapy
- CDMO Sterile Injectables
- Contract Research, Development and Manufacturing Organisation
- Proprietary Novel Drugs
- Radiopharma
Overview
Develops, manufactures and supplies generics and specialty pharmaceuticals. The segment provides solutions to the pharmaceutical industry across the value chain. Its product portfolio comprises specialty pharmaceuticals including injectables, comprising radiopharmaceuticals, contract manufacturing of allergy therapy products and sterile injectables; and generics, comprising active pharmaceutical ingredients (APIs), solid dosage formulations and India Branded Pharmaceuticals (IBP). IBP focuses on products for the treatment of medical conditions in the field of diabetology and cardiology
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Overview
Offers allergenic extracts and diagnostic devices for skin testing. It also manufactures and supplies venom immunotherapy products in the US. Its primary customers are healthcare professionals, particularly physicians, who utilize these products for both diagnostic purposes and the administration of immunotherapy treatment. Involved in the distribution of products in the US, Canada, Europe, and Australia.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Overview
Provides manufacturing services for sterile injectables (liquid and lyophilization), ophthalmic products (liquids, ointments, and creams), and ampoules. Provides CMO services in North America and has facilities in Spokane, US and Montreal, Canada.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Overview
Includes Drug Discovery Services and CDMO-AP businesses. - Drug Discovery Services provides drug discovery and development services under Jubilant Biosys Limited. It focuses on providing solutions to pharmaceutical companies. Its services include early-stage drug discovery, as well as scaling up the production of novel compounds and intermediates in both non-GMP and GMP quantities. - CDMO-API provides affordable and high-quality APIs to its Solid Dosage Formulations business in the US, Europe, and the rest of the world.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Overview
This segment focuses on creating new drugs to treat cancer and autoimmune diseases by using advanced technology and algorithms to identify and develop precise therapeutics for specific patient populations.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Overview
The segment focuses on developing, producing, and commercializing products that are used for diagnosing and treating different illnesses, such as cancer, pulmonary embolism, and coronary artery disease.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Geographical Segments
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer